{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Injections%2C+Intravenous&page=4", "query": { "condition": "Injections, Intravenous", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 161, "total_pages": 17, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Injections%2C+Intravenous&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Injections%2C+Intravenous&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-22T19:39:36.568Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00000988", "title": "A Study of BMY-27857 in Patients With AIDS or AIDS Related Complex", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Stavudine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2008-08-26", "last_synced_at": "2026-10-22T19:39:36.568Z", "location_count": 2, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00000988" }, { "nct_id": "NCT02496065", "title": "Exploratory Study of Safety and ex Vivo Fluorescence of BLZ-100 in Adult Subjects With Solid Tumors Undergoing Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Tumors, Breast" ], "interventions": [ { "name": "BLZ-100", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Blaze Bioscience Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2015-07", "completion_date": "2017-01", "has_results": false, "last_update_posted_date": "2017-07-13", "last_synced_at": "2026-10-22T19:39:36.568Z", "location_count": 2, "location_summary": "Bellevue, Washington • Seattle, Washington", "locations": [ { "city": "Bellevue", "state": "Washington" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT02496065" }, { "nct_id": "NCT01027377", "title": "Study of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Subjects With Severe Hemophilia A", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Severe Hemophilia A" ], "interventions": [ { "name": "rFVIIIFc", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bioverativ Therapeutics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "MALE", "summary": "12 Years and older · Male only" }, "enrollment_count": 16, "start_date": "2009-12", "completion_date": "2011-05", "has_results": false, "last_update_posted_date": "2020-12-19", "last_synced_at": "2026-10-22T19:39:36.568Z", "location_count": 5, "location_summary": "Los Angeles, California • Sacramento, California • Waltham, Massachusetts + 2 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Waltham", "state": "Massachusetts" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT01027377" }, { "nct_id": "NCT03282461", "title": "A Microdose Evaluation Study of ABY-029 in Head and Neck Oncology Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Head and Neck Cancer" ], "interventions": [ { "name": "ABY-029", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dartmouth-Hitchcock Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 12, "start_date": "2018-01-24", "completion_date": "2020-12-18", "has_results": false, "last_update_posted_date": "2023-05-18", "last_synced_at": "2026-10-22T19:39:36.568Z", "location_count": 1, "location_summary": "Lebanon, New Hampshire", "locations": [ { "city": "Lebanon", "state": "New Hampshire" } ], "official_url": "https://clinicaltrials.gov/study/NCT03282461" }, { "nct_id": "NCT01342510", "title": "Combination of Magnesium and Lidocaine for the Pretreatment of Pain That is Caused by the Injection of Propofol", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "General Anesthesia", "Intravenous Anesthesia" ], "interventions": [ { "name": "Magnesium Sulfate", "type": "DRUG" }, { "name": "Lidocaine", "type": "DRUG" }, { "name": "Control", "type": "DRUG" }, { "name": "Lidocaine/Magnesium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Wisconsin, Madison", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 200, "start_date": "2011-04", "completion_date": "2012-04", "has_results": true, "last_update_posted_date": "2019-05-29", "last_synced_at": "2026-10-22T19:39:36.568Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT01342510" }, { "nct_id": "NCT06032546", "title": "A Study to Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion or Subcutaneous (SC) Injection of Budigalimab and/or ABBV-382", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Human Immuno-deficiency Virus (HIV) Disease" ], "interventions": [ { "name": "Budigalimab", "type": "DRUG" }, { "name": "Placebo for Budigalimab", "type": "DRUG" }, { "name": "ABBV-382", "type": "DRUG" }, { "name": "Placebo for ABBV-382", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 163, "start_date": "2023-10-12", "completion_date": "2025-09-22", "has_results": false, "last_update_posted_date": "2025-10-29", "last_synced_at": "2026-10-22T19:39:36.568Z", "location_count": 43, "location_summary": "Birmingham, Alabama • Bakersfield, California • Beverly Hills, California + 33 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Bakersfield", "state": "California" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06032546" }, { "nct_id": "NCT00000663", "title": "A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "CD4-IgG", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Day", "maximum_age": "5 Years", "sex": "ALL", "summary": "1 Day to 5 Years" }, "enrollment_count": 18, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2005-06-24", "last_synced_at": "2026-10-22T19:39:36.568Z", "location_count": 7, "location_summary": "San Diego, California • Miami, Florida • Chicago, Illinois + 4 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "Great Neck", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00000663" }, { "nct_id": "NCT06167707", "title": "Pharmacokinetics and Pharmacodynamics of Subcutaneous vs Intravenous Furosemide in Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Heart Failure", "Fluid Overload" ], "interventions": [ { "name": "SCP-111", "type": "DRUG" }, { "name": "Furosemide USP", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "scPharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "45 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "45 Years to 80 Years" }, "enrollment_count": 21, "start_date": "2024-04-19", "completion_date": "2024-06-14", "has_results": true, "last_update_posted_date": "2026-03-30", "last_synced_at": "2026-10-22T19:39:36.568Z", "location_count": 1, "location_summary": "Tampa, Florida", "locations": [ { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06167707" }, { "nct_id": "NCT02865434", "title": "Evaluating Safety of Escalating Doses of Tilmanocept by IV Injection and SPECT Imaging in Subjects With and Without RA", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Arthritis, Rheumatoid" ], "interventions": [ { "name": "Tc99m-tilmanocept", "type": "DRUG" }, { "name": "SPECT Imaging (60 Minutes post-injection)", "type": "PROCEDURE" }, { "name": "SPECT Imaging (180 Minutes post-injection)", "type": "PROCEDURE" }, { "name": "Whole body planar SPECT imaging (15 Minutes post-injection)", "type": "PROCEDURE" }, { "name": "Whole body planar SPECT imaging (60 Minutes post-injection)", "type": "PROCEDURE" }, { "name": "Whole body planar SPECT imaging (180 Minutes post-injection)", "type": "PROCEDURE" }, { "name": "Whole body planar SPECT imaging (18-20 Hours post-injection)", "type": "PROCEDURE" }, { "name": "Blood Collection for PK Testing (15 Mins Before Injection)", "type": "PROCEDURE" }, { "name": "Blood Collection for PK Testing (after injection)", "type": "PROCEDURE" }, { "name": "Blood Collection for PK Testing (15 minutes post injection)", "type": "PROCEDURE" }, { "name": "Blood Collection for PK Testing (60 minutes post injection)", "type": "PROCEDURE" }, { "name": "Blood Collection for PK Testing (180 minutes post injection)", "type": "PROCEDURE" }, { "name": "Blood Collection for PK Testing (18-20 hours post injection)", "type": "PROCEDURE" }, { "name": "Planar Image with both Hands in Field of View", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Navidea Biopharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 39, "start_date": "2017-01", "completion_date": "2018-06", "has_results": true, "last_update_posted_date": "2021-08-12", "last_synced_at": "2026-10-22T19:39:36.568Z", "location_count": 1, "location_summary": "Kettering, Ohio", "locations": [ { "city": "Kettering", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02865434" }, { "nct_id": "NCT00001118", "title": "Study of a New Anti-HIV Drug, T-20, in HIV-Infected Children", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Enfuvirtide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "12 Years", "sex": "ALL", "summary": "3 Years to 12 Years" }, "enrollment_count": 24, "start_date": null, "completion_date": "2002-12", "has_results": false, "last_update_posted_date": "2021-11-01", "last_synced_at": "2026-10-22T19:39:36.568Z", "location_count": 24, "location_summary": "La Jolla, California • Long Beach, California • Los Angeles, California + 16 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00001118" } ] }